Search alternatives:
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search), therapy resistance (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search), therapy resistance (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
-
161
-
162
-
163
Evaluation of predicted model conformations.
Published 2024Subjects: “…meropenem significantly decreased…”
-
164
MICs of meropenem alone or in combination with BLIP-II or BLIP-II-CPP against KPC-2 and NDM-1 producing <i>K</i>. <i>pneumoniae</i>.
Published 2024Subjects: “…meropenem significantly decreased…”
-
165
Cytotoxicity and hemolytic activity of the tBLIP-II and tBLIP-II-CPP.
Published 2024Subjects: “…meropenem significantly decreased…”
-
166
IC<sub>50</sub> values of tBLIP-II, tBLIP-II-CPP, and CPP-tBLIP-II recombinant proteins.
Published 2024Subjects: “…meropenem significantly decreased…”
-
167
Construction, expression and purification of recombinant proteins.
Published 2024Subjects: “…meropenem significantly decreased…”
-
168
Predicted structures of the recombinant proteins rotating in different angles.
Published 2024Subjects: “…meropenem significantly decreased…”
-
169
-
170
Assessment of the predicted three-dimensional structures of tBLIP-II, tBLIP-II-CPP, and CPP-BLIP-II.
Published 2024Subjects: “…meropenem significantly decreased…”
-
171
The time-kill curve analysis of combined treatment.
Published 2024Subjects: “…meropenem significantly decreased…”
-
172
Determination of IC<sub>50</sub> values for tBLIP-II, tBLIP-II-CPP, and CPP-tBLIP-II.
Published 2024Subjects: “…meropenem significantly decreased…”
-
173
The results of the cytotoxic and hemolytic activities of tBLIP-II and tBLIP-II-CPP.
Published 2024Subjects: “…meropenem significantly decreased…”
-
174
The minimal data set used for plotting the kinetic growth curve.
Published 2024Subjects: “…meropenem significantly decreased…”
-
175
-
176
-
177
DataSheet_2_Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.xlsx
Published 2022“…To better understand the disease pathogenesis and find novel therapeutic targets, we established a mouse model of steroid (dexamethasone (DEX)) resistant asthma exacerbation using ovalbumin (OVA) and influenza virus (FLU) infection. …”
-
178
DataSheet_1_Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.docx
Published 2022“…To better understand the disease pathogenesis and find novel therapeutic targets, we established a mouse model of steroid (dexamethasone (DEX)) resistant asthma exacerbation using ovalbumin (OVA) and influenza virus (FLU) infection. …”
-
179
-
180